
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Epidemiology Biomarkers & Prevention, Vol 7, Issue 12 1101-1108, Copyright © 1998 by American Association for Cancer Research
ARTICLES |
X Xu, AM Duncan, BE Merz and MS Kurzer
Department of Food Science and Nutrition, University of Minnesota, St. Paul 55108, USA.
Isoflavones and lignans are soy phytoestrogens that have been suggested to be anticarcinogenic. The mechanisms by which they exert cancer-preventive effects may involve modulation of estrogen synthesis and metabolism. To evaluate this hypothesis, a randomized, cross-over soy isoflavone feeding study was performed in 12 healthy premenopausal women. The study consisted of three diet periods, each separated by a washout of approximately 3 weeks. Each diet period lasted for three menstrual cycles plus 9 days (averaging approximately 100 days), during which subjects consumed their habitual diets supplemented with soy protein powder providing 0.16 (control diet), 1.01, or 2.01 mg of total isoflavones per kg of body weight per day (10+/-1.1, 65+/-9.4, or 129+/-16 mg/day, respectively). A 72-h urine sample was collected during the midfollicular phase (days 7-9) of the fourth menstrual cycle in each diet period. Urine samples were analyzed for 10 phytoestrogens and 15 endogenous estrogens and their metabolites by a capillary gas chromatography-mass spectrometry method. Urinary excretion of isoflavonoids and lignans significantly increased with increased isoflavone consumption. Compared with the control diet, increased isoflavone consumption decreased urinary excretion of estradiol, estrone, estriol, and total estrogens, as well as excretion of the hypothesized genotoxic estrogen metabolites, 16alpha-hydroxyestrone, 4-hydroxyestrone, and 4-hydroxyestradiol. Of importance are the observations of a significant increase in the 2-hydroxyestrone/16alpha-hydroxyestrone ratio and a decrease in the genotoxic/total estrogens ratio. These data suggest that soy isoflavone consumption may exert cancer-preventive effects by decreasing estrogen synthesis and altering metabolism away from genotoxic metabolites toward inactive metabolites.
This article has been cited by other articles:
![]() |
J. M. Hamilton-Reeves, S. A. Rebello, W. Thomas, J. W. Slaton, and M. S. Kurzer Soy Protein Isolate Increases Urinary Estrogens and the Ratio of 2:16{alpha}-Hydroxyestrone in Men at High Risk of Prostate Cancer J. Nutr., October 1, 2007; 137(10): 2258 - 2263. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Greenlee, C. Atkinson, F. Z. Stanczyk, and J. W. Lampe A Pilot and Feasibility Study on the Effects of Naturopathic Botanical and Dietary Interventions on Sex Steroid Hormone Metabolism in Premenopausal Women Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1601 - 1609. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Padilla-Banks, W. N. Jefferson, and R. R. Newbold Neonatal Exposure to the Phytoestrogen Genistein Alters Mammary Gland Growth and Developmental Programming of Hormone Receptor Levels Endocrinology, October 1, 2006; 147(10): 4871 - 4882. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Sowers, S. Crawford, D. S. McConnell, J. F. Randolph Jr., E. B. Gold, M. K. Wilkin, and B. Lasley Selected Diet and Lifestyle Factors Are Associated with Estrogen Metabolites in a Multiracial/Ethnic Population of Women J. Nutr., June 1, 2006; 136(6): 1588 - 1595. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Dillingham, B. L. McVeigh, J. W. Lampe, and A. M. Duncan Soy Protein Isolates of Varying Isoflavone Content Exert Minor Effects on Serum Reproductive Hormones in Healthy Young Men J. Nutr., March 1, 2005; 135(3): 584 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Nettleton, K. A. Greany, W. Thomas, K. E. Wangen, H. Adlercreutz, and M. S. Kurzer The Effect of Soy Consumption on the Urinary 2:16-Hydroxyestrone Ratio in Postmenopausal Women Depends on Equol Production Status but Is Not Influenced by Probiotic Consumption J. Nutr., March 1, 2005; 135(3): 603 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Maskarinec, A. A. Franke, A. E. Williams, S. Hebshi, C. Oshiro, S. Murphy, and F. Z. Stanczyk Effects of a 2-Year Randomized Soy Intervention on Sex Hormone Levels in Premenopausal Women Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1736 - 1744. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Nettleton, K. A. Greany, W. Thomas, K. E. Wangen, H. Adlercreutz, and M. S. Kurzer Plasma Phytoestrogens Are Not Altered by Probiotic Consumption in Postmenopausal Women with and without a History of Breast Cancer J. Nutr., August 1, 2004; 134(8): 1998 - 2003. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D Brooks, W. E Ward, J. E Lewis, J. Hilditch, L. Nickell, E. Wong, and L. U Thompson Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy Am. J. Clinical Nutrition, February 1, 2004; 79(2): 318 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Madani, J. Prost, M. Narce, and J. Belleville VLDL Metabolism in Rats Is Affected by the Concentration and Source of Dietary Protein J. Nutr., December 1, 2003; 133(12): 4102 - 4106. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Horn-Ross, E. M. John, A. J. Canchola, S. L. Stewart, and M. M. Lee Phytoestrogen Intake and Endometrial Cancer Risk J Natl Cancer Inst, August 6, 2003; 95(15): 1158 - 1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Tice, B. Ettinger, K. Ensrud, R. Wallace, T. Blackwell, and S. R. Cummings Phytoestrogen Supplements for the Treatment of Hot Flashes: The Isoflavone Clover Extract (ICE) Study: A Randomized Controlled Trial JAMA, July 9, 2003; 290(2): 207 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Lampe Isoflavonoid and Lignan Phytoestrogens as Dietary Biomarkers J. Nutr., March 1, 2003; 133(3): 956S - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. I. Block, A. Constantinou, L. Hilakivi-Clarke, C. Hughes, D. Tripathy, J. A. Tice, K. Block, and K. Block Point-Counterpoint: Soy Intake for Breast Cancer Patients Integr Cancer Ther, March 1, 2002; 1(1): 90 - 100. [PDF] |
||||
![]() |
C. Atkinson, H. E. Skor, E. D. Fitzgibbons, D. Scholes, C. Chen, K. Wahala, S. M. Schwartz, and J. W. Lampe Overnight Urinary Isoflavone Excretion in a Population of Women Living in the United States, and Its Relationship to Isoflavone Intake Cancer Epidemiol. Biomarkers Prev., March 1, 2002; 11(3): 253 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Kurzer Hormonal Effects of Soy in Premenopausal Women and Men J. Nutr., March 1, 2002; 132(3): 570S - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Maskarinec, A. E. Williams, J. S. Inouye, F. Z. Stanczyk, and A. A. Franke A Randomized Isoflavone Intervention among Premenopausal Women Cancer Epidemiol. Biomarkers Prev., February 1, 2002; 11(2): 195 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Horn-Ross, K. J. Hoggatt, and M. M. Lee Phytoestrogens and Thyroid Cancer Risk: The San Francisco Bay Area Thyroid Cancer Study Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 43 - 49. [Abstract] [Full Text] |
||||
![]() |
V. W Persky, M. E Turyk, L. Wang, S. Freels, R. Chatterton Jr, S. Barnes, J. Erdman Jr, D. W Sepkovic, H L. Bradlow, and S. Potter Effect of soy protein on endogenous hormones in postmenopausal women Am. J. Clinical Nutrition, January 1, 2002; 75(1): 145 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Burdette, J. Liu, D. Lantvit, E. Lim, N. Booth, K. P. L. Bhat, S. Hedayat, R. B. Van Breemen, A. I. Constantinou, J. M. Pezzuto, et al. Trifolium pratense (Red Clover) Exhibits Estrogenic Effects In Vivo in Ovariectomized Sprague-Dawley Rats J. Nutr., January 1, 2002; 132(1): 27 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. FABIAN and B. F. KIMLER Beyond Tamoxifen: New Endpoints for Breast Cancer Chemoprevention, New Drugs for Breast Cancer Prevention Ann. N.Y. Acad. Sci., December 1, 2001; 952(1): 44 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mei, S. S. C. Yeung, and A. W. C. Kung High Dietary Phytoestrogen Intake Is Associated with Higher Bone Mineral Density in Postmenopausal but Not Premenopausal Women J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5217 - 5221. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Messina and C. L. Loprinzi Soy for Breast Cancer Survivors: A Critical Review of the Literature J. Nutr., November 1, 2001; 131(11): 3095S - 3108. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-J. W. Lu, K. E. Anderson, J. J. Grady, and M. Nagamani Effects of an Isoflavone-Free Soy Diet on Ovarian Hormones in Premenopausal Women J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3045 - 3052. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Lampe, H. E. Skor, S. Li, K. Wähälä, W. N. Howald, and C. Chen Wheat Bran and Soy Protein Feeding Do Not Alter Urinary Excretion of the Isoflavan Equol in Premenopausal Women J. Nutr., March 1, 2001; 131(3): 740 - 744. [Abstract] [Full Text] |
||||
![]() |
X. Xu, A. M. Duncan, K. E. Wangen, and M. S. Kurzer Soy Consumption Alters Endogenous Estrogen Metabolism in Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., August 1, 2000; 9(8): 781 - 786. [Abstract] [Full Text] |
||||
![]() |
H. C. Chang, M. I. Churchwell, K. B. Delclos, R. R. Newbold, and D. R. Doerge Mass Spectrometric Determination of Genistein Tissue Distribution in Diet-Exposed Sprague-Dawley Rats J. Nutr., August 1, 2000; 130(8): 1963 - 1970. [Abstract] [Full Text] |
||||
![]() |
A. M. Duncan, B. E. Merz-Demlow, X. Xu, W. R. Phipps, and M. S. Kurzer Premenopausal Equol Excretors Show Plasma Hormone Profiles Associated with Lowered Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., June 1, 2000; 9(6): 581 - 586. [Abstract] [Full Text] |
||||
![]() |
L. R. White, H. Petrovitch, G. W. Ross, K. Masaki, J. Hardman, J. Nelson, D. Davis, and W. Markesbery Brain Aging and Midlife Tofu Consumption J. Am. Coll. Nutr., April 1, 2000; 19(2): 242 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-J. W. Lu, M. Cree, S. Josyula, M. Nagamani, J. J. Grady, and K. E. Anderson Increased Urinary Excretion of 2-Hydroxyestrone but not 16{{alpha}}-Hydroxyestrone in Premenopausal Women during a Soya Diet Containing Isoflavones Cancer Res., March 1, 2000; 60(5): 1299 - 1305. [Abstract] [Full Text] |
||||
![]() |
M. S. Kurzer Hormonal Effects of Soy Isoflavones: Studies in Premenopausal and Postmenopausal Women J. Nutr., March 1, 2000; 130(3): 660 - 660. [Full Text] |
||||
![]() |
X. Xu, A. M. Duncan, B. E. Merz-Demlow, W. R. Phipps, and M. S. Kurzer Menstrual Cycle Effects on Urinary Estrogen Metabolites J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 3914 - 3918. [Abstract] [Full Text] |
||||
![]() |
M. Messina Soy, soy phytoestrogens (isoflavones), and breast cancer Am. J. Clinical Nutrition, October 1, 1999; 70(4): 574 - 575. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |